Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific …

J Yu, X He, Z Wang, Y Wang, S Liu, X Li, Y Huang - Nanoscale, 2021 - pubs.rsc.org
Immune checkpoint blockade (ICB) therapy in combination with immunogenic death (ICD)
triggered by photothermal therapy (PTT) and oxaliplatin (OXA) treatment was expected to …
被引用次数：35 相关文章

Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific …

J Yu, X He, Z Wang, Y Wang, S Liu, X Li, Y Huang - Nanoscale, 2021 - europepmc.org
Immune checkpoint blockade (ICB) therapy in combination with immunogenic death (ICD)
triggered by photothermal therapy (PTT) and oxaliplatin (OXA) treatment was expected to …

Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific …

J Yu, X He, Z Wang, Y Wang, S Liu, X Li… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint blockade (ICB) therapy in combination with immunogenic death (ICD)
triggered by photothermal therapy (PTT) and oxaliplatin (OXA) treatment was expected to …

Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific …

J Yu, X He, Z Wang, Y Wang, S Liu, X Li, Y Huang - Nanoscale, 2021 - cir.nii.ac.jp
Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal
therapy <i>via</i> a thermosensitive liposome system to stimulate tumor-specific immunological …